🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vera Bril

University Health Network

ORCID: 0000-0002-5805-4883

Also affiliated with University of Toronto, Toronto General Hospital, Dean Martin Neuromuscular Clinic

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis”.

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Neurology(2022)10.1212/wnl.0000000000201501

N/A

1.2DataRank · unranked

25 citations

Andrzej Szczudlik, Antanas Vaitkus, Csilla Rózsa, Anna Kostera‐Pruszczyk, Petr Hon +20 more

Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis

Neurology(2023)10.1212/wnl.0000000000207937

N/A

0.652DataRank · unranked

76 citations

Jeffrey T. Guptill, Vera Bril, Josep Gámez, Sven G. Meuth, Richard J. Nowak +12 more

Rapid Corneal Nerve Fiber Loss: A Marker of Diabetic Neuropathy Onset and Progression

Diabetes Care(2020)10.2337/dc19-0951

N/A

0DataRank · unranked

63 citations

Leif Erik Lovblom, Maryam Ferdousi, Elise M. Halpern, Maria Jeziorska, Danièle Pacaud +11 more

Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51946

N/A

0DataRank · unranked

20 citations

Ari Breiner, Vera Bril, Jeffrey A. Allen, Shaida Khan, Todd Levine +8 more

Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults With Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-label Extension

Neurology(2024)10.1212/01.wnl.0001051364.68802.aa

N/A

0DataRank · unranked

0 citations

Renato Mantegazza, Djillali Annane, Masahisa Katsuno, Andreas Meisel, Michael Nicolle +5 more

Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients

Neurology(2022)10.1212/01.wnl.0000903304.73134.e3

N/A

0DataRank · unranked

2 citations

Jeff Guptill, Carlo Antozzi, Vera Bril, Josep Gámez, Sven G. Meuth +8 more

ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable

Orphanet Journal of Rare Diseases(2021)10.1186/s13023-021-01834-0

N/A

0DataRank · unranked

16 citations

Michaela Auer‐Grumbach, John L. Berk, Chiara Briani, Vera Bril, Teresa Coelho +22 more